Where is the live CopyMark page for USPTO serial 97033399?

The live record is at https://getcopymark.com/trademark/97033399. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns LUMOS PHARMA?

According to the public USPTO record for serial number 97033399, the listed owner(s) include: LUMOS PHARMA, LLC, Lumos Pharma, Inc..

What is USPTO serial number 97033399?

Serial number 97033399 is the USPTO application identifier for the mark LUMOS PHARMA. It is used to track examination, publication, and registration of this trademark.

Which trademark classes cover LUMOS PHARMA?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: LUMOS PHARMA Serial# 97033399 | status 654; last event RCSC | Trademark Info & Attorney Guidance

Q: What is the current status of LUMOS PHARMA?

LUMOS PHARMA (97033399) currently shows USPTO status code 654 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with LUMOS PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

LUMOS PHARMA, LLC
AMES, IA, US
Other trademarks owned by LUMOS PHARMA, LLC
Lumos Pharma, Inc.
Austin, TX, US
Other trademarks owned by Lumos Pharma, Inc.

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Luke T. Mohrhauser

Luke T. Mohrhauser MCKEE, VOORHEES & SEASE, P.L.C.801 GRAND AVE., STE. 3200DES MOINES, IA 50309-2721UNITED STATES

Goods and services

Class	Description	Status	First use
005	Therapeutic pharmaceuticals to treat rare diseases in children, namely Pediatric Growth Hormone Deficiency (PGHD)	ACTIVE	Dec 22, 2014

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Nov 9, 2026	RCSC	REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED	—
May 12, 2026	RCSC	REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED	—
Oct 31, 2025	RCSC	REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED	—
Sep 2, 2025	ASGN	AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP	—
Apr 28, 2025	RCSC	REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED	—
Oct 28, 2024	RCSC	REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED	—
Oct 28, 2024	RCSC	REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED	—
Oct 23, 2024	RCSC	REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED	—
Dec 7, 2023	RCSC	REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED	—
Jun 8, 2023	RCSC	REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED	—
Dec 9, 2022	GNS3	NOTIFICATION OF LETTER OF SUSPENSION E-MAILED	—
Dec 9, 2022	GNSL	LETTER OF SUSPENSION E-MAILED	—
Dec 9, 2022	CNSL	SUSPENSION LETTER WRITTEN	—
Nov 30, 2022	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Nov 29, 2022	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Nov 29, 2022	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 22, 2022	GNRN	NOTIFICATION OF NON-FINAL ACTION E-MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 22, 2022	GNRT	NON-FINAL ACTION E-MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 22, 2022	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 21, 2022	DOCK	ASSIGNED TO EXAMINER	—
Oct 22, 2021	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	—
Sep 21, 2021	NWAP	NEW APPLICATION ENTERED	—

LUMOS PHARMA